Testing the Psychometric Characteristics of EQ-5D-5L and Respiratory Bolt-ons Using a Sample of the Australian Population

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2024 Oct 27

PMID 39461931

Authors

Mina Bahrampour

Slavica Kochovska

David C Currow

Rosalie Viney

Brendan Mulhern

Affiliations

Soon will be listed here.

Abstract

Purpose: The EQ-5D has been used to assess health related quality of life (HRQoL) in respiratory conditions. However, the core descriptive system may not be sensitive to all the HRQoL impacts of these conditions. To increase the sensitivity of the descriptive system, two respiratory specific bolt-ons, have been developed. Psychometric assessment of the bolt-ons in comparison to other validated instruments is required to facilitate their use. Therefore, the aim of this study is to test the psychometric characteristics of the EQ-5D-5L + R using a large dataset collected in Australia.

Methods: A cross-sectional online survey was used to recruit adult respondents (≥ 18 years) representative of the Australian population. Descriptive and psychometric analyses were used to understand the performance of the EQ-5D-5L and bolt-ons in comparison to other validated instruments. The construct validity was estimated using correlations. Known-group validity was tested to determine the sensitivity of the instruments to differences across different severity groups.

Results: Overall 10,033 respondents (52% female) completed the survey, of which 300 had a respiratory condition. There were moderate to high correlation between bolt-ons with EQ-5D-5L and WHODAS. The EQ-5D-5L + bolt-ons slightly reduced the ceiling effect in comparison to the EQ-5D-5L. The effect size was larger for people with respiratory conditions than people who did not have a respiratory condition.

Conclusion: The results show that adding the respiratory bolt-on to the EQ-5D-5L might slightly improve the instruments descriptive sensitivity. The choice of bolt-on may be driven by whether overall problems or limitations are being measured.

References

Garcia-Gordillo M, Collado-Mateo D, Olivares P, Adsuar J, Merellano-Navarro E . A Cross-sectional Assessment of Health-related Quality of Life among Patients with Chronic Obstructive Pulmonary Disease. Iran J Public Health. 2017; 46(8):1046-1053. PMC: 5575383. View

Longworth L, Yang Y, Young T, Mulhern B, Alava M, Mukuria C . Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014; 18(9):1-224. PMC: 4780954. DOI: 10.3310/hta18090. View

Petrillo J, Van Nooten F, Jones P, Rutten-van Molken M . Utility estimation in chronic obstructive pulmonary disease: a preference for change?. Pharmacoeconomics. 2011; 29(11):917-32. DOI: 10.2165/11589280-000000000-00000. View

Esquinas C, Ramon M, Nunez A, Molina J, Quintano J, Roman-Rodriguez M . Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Qual Life Res. 2019; 29(3):607-617. DOI: 10.1007/s11136-019-02340-4. View

Geraerds A, Bonsel G, Polinder S, Panneman M, Janssen M, Haagsma J . Does the EQ-5D-5L benefit from extension with a cognitive domain: Testing a multi-criteria psychometric strategy in trauma patients. Qual Life Res. 2020; 29(9):2541-2551. PMC: 7434722. DOI: 10.1007/s11136-020-02496-4. View

Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L . Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Qual Life Res. 2012; 22(7):1707-16. DOI: 10.1007/s11136-012-0318-0. View

Sullivan P, Ghushchyan V, Campbell J, Globe G, Bender B, Magid D . Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes. Qual Life Res. 2016; 25(12):3017-3026. DOI: 10.1007/s11136-016-1357-8. View

Whalley D, Globe G, Crawford R, Doward L, Tafesse E, Brazier J . Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective. Health Qual Life Outcomes. 2018; 16(1):160. PMC: 6090889. DOI: 10.1186/s12955-018-0970-3. View

Swinburn P, Lloyd A, Boye K, Edson-Heredia E, Bowman L, Janssen B . Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. Value Health. 2013; 16(8):1156-62. DOI: 10.1016/j.jval.2013.10.003. View

10.

M Nolan C, Longworth L, Lord J, Canavan J, Jones S, Kon S . The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016; 71(6):493-500. PMC: 4893131. DOI: 10.1136/thoraxjnl-2015-207782. View

11.

Currow D, Chang S, Grande E, Ferreira D, Kochovska S, Kinchin I . Quality of Life Changes With Duration of Chronic Breathlessness: A Random Sample of Community-Dwelling People. J Pain Symptom Manage. 2020; 60(4):818-827.e4. DOI: 10.1016/j.jpainsymman.2020.05.015. View

12.

Maqhuzu P, Szentes B, Kreuter M, Bahmer T, Kahn N, Claussen M . Determinants of health-related quality of life decline in interstitial lung disease. Health Qual Life Outcomes. 2020; 18(1):334. PMC: 7542726. DOI: 10.1186/s12955-020-01570-2. View

13.

de Graaf J, Kuijpers M, Visser-Meily J, Kappelle L, Post M . Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke. Clin Rehabil. 2020; 34(4):545-550. DOI: 10.1177/0269215520907990. View

14.

Hoogendoorn M, Jowett S, Dickens A, Jordan R, Enocson A, Adab P . Performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study. Value Health. 2021; 24(11):1667-1675. DOI: 10.1016/j.jval.2021.05.006. View

15.

Zacarias L, Camara K, Alves B, Morano M, Viana C, MontAlverne D . Validation of the World Health Organization Disability Assessment Schedule (WHODAS 2.0) for individuals with COPD. Disabil Rehabil. 2021; 44(19):5663-5668. DOI: 10.1080/09638288.2021.1948117. View

16.

Mulhern B, Sampson C, Haywood P, Addo R, Page K, Mott D . Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons. Qual Life Res. 2022; 31(10):3041-3048. PMC: 9470642. DOI: 10.1007/s11136-022-03138-7. View

17.

Geraerds A, Bonsel G, Janssen M, Finch A, Polinder S, Haagsma J . Methods Used to Identify, Test, and Assess Impact on Preferences of Bolt-Ons: A Systematic Review. Value Health. 2021; 24(6):901-916. DOI: 10.1016/j.jval.2020.12.011. View

18.

Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T, Longworth L . An exploratory study to test the impact on three "bolt-on" items to the EQ-5D. Value Health. 2015; 18(1):52-60. PMC: 4309886. DOI: 10.1016/j.jval.2014.09.004. View

19.

Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

20.

Pickard A, Wilke C, Jung E, Patel S, Stavem K, Lee T . Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008; 102(4):519-36. DOI: 10.1016/j.rmed.2007.11.016. View